DDAH1 and endothelial dysfunction: Decreased DDAH expression/activity is evident in disease states associated with endothelial dysfunction and is believed to be the mechanism responsible for the increase in methylarginine levels and the subsequent asymmetric dimethylarginine (ADMA)-mediated endothelial nitric oxide synthase impairment [37,38].